+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Beta Lactam and Beta Lactamase Inhibitors Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • July 2022
  • Region: Global
  • TechNavio
  • ID: 5632841
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the beta-lactam and beta-lactamase inhibitors market and it is poised to grow by $ 9.04 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. The report on the beta-lactam and beta-lactamase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special regulatory designations, easy availability of OTC drugs, and increased consumption in low- and middle-income countries. The beta-lactam and beta-lactamase inhibitors market analysis includes the administration segment and geographic landscape.

The publisher's beta-lactam and beta-lactamase inhibitors market is segmented as below:

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising prevalence of infectious diseases as one of the prime reasons driving the beta-lactam and beta-lactamase inhibitors market growth during the next few years. Also, strategic alliances and M&A, and an increasing geriatric population will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the beta-lactam and beta-lactamase inhibitors market covers the following areas:
  • Beta-lactam and beta-lactamase inhibitors market sizing
  • Beta-lactam and beta-lactamase inhibitors market forecast
  • Beta-lactam and beta-lactamase inhibitors market industry analysis .
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading beta-lactam and beta-lactamase inhibitors market vendors that include Abbott Laboratories, AbbVie Inc., Aristo Pharmaceuticals Pvt Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Livealth Biopharma Pvt. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Pragati Biocare Pvt. Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd. Also, the beta-lactam and beta-lactamase inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.uch as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Route of Administration
5.1 Market segments
Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
5.2 Comparison by Route of Administration
Exhibit 26: Chart on Comparison by Route of Administration
Exhibit 27: Data Table on Comparison by Route of Administration
5.3 Oral - Market size and forecast 2021-2026
Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.4 Intravenous - Market size and forecast 2021-2026
Exhibit 32: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Route of Administration
Exhibit 40: Market opportunity by Route of Administration ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 89: Abbott Laboratories - Overview
Exhibit 90: Abbott Laboratories - Business segments
Exhibit 91: Abbott Laboratories - Key news
Exhibit 92: Abbott Laboratories - Key offerings
Exhibit 93: Abbott Laboratories - Segment focus
10.4 AbbVie Inc.
Exhibit 94: AbbVie Inc. - Overview
Exhibit 95: AbbVie Inc. - Product / Service
Exhibit 96: AbbVie Inc. - Key offerings
10.5 Aristo Pharmaceuticals Pvt Ltd.
Exhibit 97: Aristo Pharmaceuticals Pvt Ltd. - Overview
Exhibit 98: Aristo Pharmaceuticals Pvt Ltd. - Product / Service
Exhibit 99: Aristo Pharmaceuticals Pvt Ltd. - Key offerings
10.6 Cipla Ltd.
Exhibit 100: Cipla Ltd. - Overview
Exhibit 101: Cipla Ltd. - Business segments
Exhibit 102: Cipla Ltd. - Key news
Exhibit 103: Cipla Ltd. - Key offerings
Exhibit 104: Cipla Ltd. - Segment focus
10.7 Dr. Reddys Laboratories Ltd.
Exhibit 105: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 106: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 107: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 108: Dr. Reddys Laboratories Ltd. - Segment focus
10.8 F. Hoffmann La Roche Ltd.
Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
10.9 GlaxoSmithKline Plc
Exhibit 114: GlaxoSmithKline Plc - Overview
Exhibit 115: GlaxoSmithKline Plc - Business segments
Exhibit 116: GlaxoSmithKline Plc - Key news
Exhibit 117: GlaxoSmithKline Plc - Key offerings
Exhibit 118: GlaxoSmithKline Plc - Segment focus
10.10 Johnson and Johnson
Exhibit 119: Johnson and Johnson - Overview
Exhibit 120: Johnson and Johnson - Business segments
Exhibit 121: Johnson and Johnson - Key news
Exhibit 122: Johnson and Johnson - Key offerings
Exhibit 123: Johnson and Johnson - Segment focus
10.11 Merck and Co. Inc.
Exhibit 124: Merck and Co. Inc. - Overview
Exhibit 125: Merck and Co. Inc. - Business segments
Exhibit 126: Merck and Co. Inc. - Key news
Exhibit 127: Merck and Co. Inc. - Key offerings
Exhibit 128: Merck and Co. Inc. - Segment focus
10.12 Pfizer Inc.
Exhibit 129: Pfizer Inc. - Overview
Exhibit 130: Pfizer Inc. - Product / Service
Exhibit 131: Pfizer Inc. - Key news
Exhibit 132: Pfizer Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
11.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
11.5 List of abbreviations
Exhibit 139: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits 25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Route of Administration
Exhibits 27: Data Table on Comparison by Route of Administration
Exhibits 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Route of Administration ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Abbott Laboratories - Overview
Exhibits 90: Abbott Laboratories - Business segments
Exhibits 91: Abbott Laboratories - Key news
Exhibits 92: Abbott Laboratories - Key offerings
Exhibits 93: Abbott Laboratories - Segment focus
Exhibits 94: AbbVie Inc. - Overview
Exhibits 95: AbbVie Inc. - Product / Service
Exhibits 96: AbbVie Inc. - Key offerings
Exhibits 97: Aristo Pharmaceuticals Pvt Ltd. - Overview
Exhibits 98: Aristo Pharmaceuticals Pvt Ltd. - Product / Service
Exhibits 99: Aristo Pharmaceuticals Pvt Ltd. - Key offerings
Exhibits 100: Cipla Ltd. - Overview
Exhibits 101: Cipla Ltd. - Business segments
Exhibits 102: Cipla Ltd. - Key news
Exhibits 103: Cipla Ltd. - Key offerings
Exhibits 104: Cipla Ltd. - Segment focus
Exhibits 105: Dr. Reddys Laboratories Ltd. - Overview
Exhibits 106: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits 107: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits 108: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits 109: F. Hoffmann La Roche Ltd. - Overview
Exhibits 110: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 111: F. Hoffmann La Roche Ltd. - Key news
Exhibits 112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 113: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 114: GlaxoSmithKline Plc - Overview
Exhibits 115: GlaxoSmithKline Plc - Business segments
Exhibits 116: GlaxoSmithKline Plc - Key news
Exhibits 117: GlaxoSmithKline Plc - Key offerings
Exhibits 118: GlaxoSmithKline Plc - Segment focus
Exhibits 119: Johnson and Johnson - Overview
Exhibits 120: Johnson and Johnson - Business segments
Exhibits 121: Johnson and Johnson - Key news
Exhibits 122: Johnson and Johnson - Key offerings
Exhibits 123: Johnson and Johnson - Segment focus
Exhibits 124: Merck and Co. Inc. - Overview
Exhibits 125: Merck and Co. Inc. - Business segments
Exhibits 126: Merck and Co. Inc. - Key news
Exhibits 127: Merck and Co. Inc. - Key offerings
Exhibits 128: Merck and Co. Inc. - Segment focus
Exhibits 129: Pfizer Inc. - Overview
Exhibits 130: Pfizer Inc. - Product / Service
Exhibits 131: Pfizer Inc. - Key news
Exhibits 132: Pfizer Inc. - Key offerings
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Validation techniques employed for market sizing
Exhibits 138: Information sources
Exhibits 139: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global beta-lactam and beta-lactamase inhibitors market: Abbott Laboratories, AbbVie Inc., Aristo Pharmaceuticals Pvt Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Livealth Biopharma Pvt. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Pragati Biocare Pvt. Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zydus Lifesciences Ltd.

Commenting on the report, an analyst from the publishing company said: "The latest trend gaining momentum in the market is rising prevalence of infectious diseases."

According to the report, one of the major drivers for this market is the special regulatory designations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AbbVie Inc.
  • Aristo Pharmaceuticals Pvt Ltd.
  • Aurobindo Pharma Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Dr. Reddys Laboratories Ltd.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson
  • Livealth Biopharma Pvt. Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Pragati Biocare Pvt. Ltd.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.